Cargando…
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077142/ https://www.ncbi.nlm.nih.gov/pubmed/36987538 http://dx.doi.org/10.2340/actadv.v103.4526 |
| _version_ | 1785020260119740416 |
|---|---|
| author | GNESOTTO, Laura MIOSO, Guido BARDAZZI, Federico FILIPPI, Federica DI LERNIA, Vito MOTOLESE, Alberto DI NUZZO, Sergio CONTI, Andrea ARGINELLI, Federica CORAZZA, Monica ODORICI, Giulia BORGHI, Alessandro GISONDI, Paolo NALDI, Luigi DAPAVO, Paolo PARODI, Aurora BURLANDO, Martina PIASERICO, Stefano |
| author_facet | GNESOTTO, Laura MIOSO, Guido BARDAZZI, Federico FILIPPI, Federica DI LERNIA, Vito MOTOLESE, Alberto DI NUZZO, Sergio CONTI, Andrea ARGINELLI, Federica CORAZZA, Monica ODORICI, Giulia BORGHI, Alessandro GISONDI, Paolo NALDI, Luigi DAPAVO, Paolo PARODI, Aurora BURLANDO, Martina PIASERICO, Stefano |
| author_sort | GNESOTTO, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10077142 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100771422023-04-07 Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study GNESOTTO, Laura MIOSO, Guido BARDAZZI, Federico FILIPPI, Federica DI LERNIA, Vito MOTOLESE, Alberto DI NUZZO, Sergio CONTI, Andrea ARGINELLI, Federica CORAZZA, Monica ODORICI, Giulia BORGHI, Alessandro GISONDI, Paolo NALDI, Luigi DAPAVO, Paolo PARODI, Aurora BURLANDO, Martina PIASERICO, Stefano Acta Derm Venereol Short Communication Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023-03-28 /pmc/articles/PMC10077142/ /pubmed/36987538 http://dx.doi.org/10.2340/actadv.v103.4526 Text en © Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) |
| spellingShingle | Short Communication GNESOTTO, Laura MIOSO, Guido BARDAZZI, Federico FILIPPI, Federica DI LERNIA, Vito MOTOLESE, Alberto DI NUZZO, Sergio CONTI, Andrea ARGINELLI, Federica CORAZZA, Monica ODORICI, Giulia BORGHI, Alessandro GISONDI, Paolo NALDI, Luigi DAPAVO, Paolo PARODI, Aurora BURLANDO, Martina PIASERICO, Stefano Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study |
| title | Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study |
| title_full | Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study |
| title_fullStr | Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study |
| title_full_unstemmed | Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study |
| title_short | Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study |
| title_sort | dimethyl fumarate treatment in patients with moderate-to-severe psoriasis: a 52-week real-life study |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077142/ https://www.ncbi.nlm.nih.gov/pubmed/36987538 http://dx.doi.org/10.2340/actadv.v103.4526 |
| work_keys_str_mv | AT gnesottolaura dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT miosoguido dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT bardazzifederico dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT filippifederica dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT dilerniavito dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT motolesealberto dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT dinuzzosergio dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT contiandrea dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT arginellifederica dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT corazzamonica dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT odoricigiulia dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT borghialessandro dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT gisondipaolo dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT naldiluigi dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT dapavopaolo dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT parodiaurora dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT burlandomartina dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy AT piasericostefano dimethylfumaratetreatmentinpatientswithmoderatetoseverepsoriasisa52weekreallifestudy |